Liver Cirrhosis, Experimental - Chemically induced
Research News and Information

Sunday, November 22, 2009

Effect of early propranolol administration on portal hypertensive gastropathy in cirrhotic rats.

12 Sep 2009 AIM: To investigate any protective effect of early propranolol administration in the development of portal hypertensive gastropathy in cirrhotic rats. METHODS: For the development of liver cirrhosis and portal hypertensive gastropathy, 60 rats ... Read more...

Changes in microRNAs associated with hepatic stellate cell activation status identify signaling pathways.

8 Aug 2009 Activation of hepatic stellate cells (HSCs), which is regulated by multiple signal transduction pathways, is the key event in liver fibrosis. Moreover, members of these pathways are important targets for microRNAs (miRNAs). To better understand the ... Read more...

Active matrix metalloproteinase-2 promotes apoptosis of hepatic stellate cells via the cleavage of cellular N-cadherin.

30 Jul 2009 BACKGROUND AND AIMS: Hepatic stellate cells (HSC) are known to synthesise excess matrix that characterises liver fibrosis and cirrhosis. Activated HSC express the matrix-degrading matrix metalloproteinase enzymes (MMPs) and their tissue inhibitors ... Read more...

Latest indexed articles for 'Liver Cirrhosis, Experimental - Chemically induced'

These are the very latest articles for this heading:

• Effect of early propranolol administration on portal hypertensive gastropathy in cirrhotic rats. 12 Sep 2009
• Changes in microRNAs associated with hepatic stellate cell activation status identify signaling pathways. 8 Aug 2009
• Active matrix metalloproteinase-2 promotes apoptosis of hepatic stellate cells via the cleavage of cellular N-cadherin. 30 Jul 2009
• Oxidative stress, isoprostanes and hepatic fibrosis. 29 Jun 2009
• Deleterious effects of silymarin on the expression of genes controlling endothelial nitric oxide synthase activity in carbon tetrachloride-treated rat livers. 11 Jun 2009
• Adenosine triphosphate-binding cassette subfamily C member 2 is the major transporter of the hepatobiliary imaging agent (99m)Tc-mebrofenin. 10 Jun 2009
• Inhibition of hepatic damage and liver fibrosis by brain natriuretic peptide. 18 May 2009
• Improvement in dissolution of liver fibrosis in an animal model by tetrathiomolybdate. 21 Mar 2009
• Endothelin antagonism in portal hypertensive mice: implications for endothelin receptor-specific signaling in liver disease. 17 Mar 2009
• The protective effects of a fermented substance from Saccharomyces cerevisiae on carbon tetrachloride-induced liver damage in rats. 21 Feb 2009
• Retinoid metabolism in the small intestine during development of liver cirrhosis. 13 Feb 2009
• Pentoxifylline prevents pig serum-induced rat liver fibrosis by inhibiting interleukin-6 production. 10 Feb 2009
• Cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis. 12 Jan 2009
• Suppression of carbon tetrachloride-induced liver fibrosis by transplantation of a clonal mesenchymal stem cell line derived from rat bone marrow. 30 Dec 2008
• Restrictive model of compensated carbon tetrachloride-induced cirrhosis in rats. 5 Dec 2008
• An ultrasound and histomorphological analysis of experimental liver cirrhosis in rats. 30 Oct 2008
• Early propranolol administration does not prevent development of esophageal varices in cirrhotic rats. 28 Oct 2008
• [Curative effect of interferon-alpha on rat liver fibrosis induced by CCl4] 29 Sep 2008
• Superoxide dismutase gene transfer reduces portal pressure in CCl4 cirrhotic rats with portal hypertension. 29 Sep 2008
• Newly proposed fibrosis staging criterion for assessing carbon tetrachloride- and albumin complex-induced liver fibrosis in rodents. 30 Aug 2008

See a longer list of these articles.

Technical information about 'Liver Cirrhosis, Experimental'

Definition: Experimentally induced chronic injuries to the parenchymal cells in the liver to achieve a model for LIVER CIRRHOSIS.

Descriptor UI: D008106

Alternative terms: Liver Cirrhosis, Experimental; Cirrhosis, Experimental Liver; Liver Cirrhoses, Experimental; Experimental Liver Cirrhosis; Hepatic Cirrhosis, Experimental; Experimental Hepatic Cirrhosis; Cirrhoses, Experimental Liver; Experimental Liver Cirrhoses;

Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; surgery; therapy; urine; veterinary; ultrasonography; virology;

Tree Number: C06.552.630.467; E05.598.500.468;

Technical Notes: DF: LIVER CIRRHOSIS EXPER